Faes Farma
Faes Farma, officially known as Faes Farma S.A., is a prominent pharmaceutical company headquartered in Spain. Established in 1933, the company has evolved into a key player in the healthcare industry, focusing on the development, manufacturing, and marketing of innovative pharmaceutical products. With a strong presence in Europe and Latin America, Faes Farma is dedicated to therapeutic areas such as central nervous system disorders, respiratory diseases, and dermatology. The company is recognised for its unique formulations and commitment to research and development, which have led to several notable achievements in the pharmaceutical sector. Faes Farma's extensive portfolio includes both prescription medications and over-the-counter products, positioning it as a trusted name in the market. With a rich history and a forward-thinking approach, Faes Farma continues to make significant contributions to global health.
DitchCarbon Score
How does Faes Farma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Faes Farma's score of 23 is higher than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Faes Farma's reported carbon emissions
In 2023, Faes Farma reported total carbon emissions of approximately 7,580,000 kg CO2e, comprising 4,965,000 kg CO2e from Scope 1 and 2,615,000 kg CO2e from Scope 2 emissions. This marks an increase from 2022, where emissions were about 4,182,000 kg CO2e, with 3,782,000 kg CO2e from Scope 1 and 856,000 kg CO2e from Scope 2. In 2021, the company recorded total emissions of approximately 5,542,000 kg CO2e, with 3,874,000 kg CO2e from Scope 1 and 1,652,000 kg CO2e from Scope 2. Despite the fluctuations in emissions, Faes Farma has not publicly disclosed specific reduction targets or initiatives aimed at decreasing their carbon footprint. The absence of defined climate commitments or science-based targets suggests that the company may be in the early stages of developing a comprehensive climate strategy. As the pharmaceutical industry increasingly prioritises sustainability, Faes Farma's future commitments will be crucial in aligning with global climate goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 3,874,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 1,652,000 | 000,000 | 0,000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Faes Farma is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
